|
Volumn 56, Issue 6, 1998, Pages 1055-1064
|
Efavirenz
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALUMINUM MAGNESIUM HYDROXIDE;
ANTIHISTAMINIC AGENT;
AZITHROMYCIN;
CD4 ANTIGEN;
CORTICOSTEROID;
CYTOCHROME P450;
DELAVIRDINE;
EFAVIRENZ;
FAMOTIDINE;
FLUCONAZOLE;
INDINAVIR;
LAMIVUDINE PLUS ZIDOVUDINE;
NELFINAVIR;
NEVIRAPINE;
RNA DIRECTED DNA POLYMERASE;
SAQUINAVIR;
STAVUDINE;
VIRUS RNA;
AMINO ACID SUBSTITUTION;
ARTICLE;
CLINICAL TRIAL;
DIARRHEA;
DRUG BLOOD LEVEL;
DRUG CONTRAINDICATION;
DRUG ELIMINATION;
DRUG PROTEIN BINDING;
DRUG RESISTANCE;
DYSPEPSIA;
FATIGUE;
GENE MUTATION;
HEADACHE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INSOMNIA;
LYMPHOCYTE COUNT;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PAIN;
RASH;
VERTIGO;
VIRUS LOAD;
VOMITING;
ADMINISTRATION, ORAL;
ANTIVIRAL AGENTS;
DRUG ADMINISTRATION SCHEDULE;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
HIV INFECTIONS;
HIV-1;
HUMANS;
OXAZINES;
REVERSE TRANSCRIPTASE INHIBITORS;
|
EID: 0032441604
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-199856060-00014 Document Type: Article |
Times cited : (265)
|
References (34)
|